Beurs gesloten -
Nasdaq
22:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
208,9
USD
|
+3,18%
|
|
+7,47%
|
-19,27%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
53.543
|
37.679
|
35.242
|
39.877
|
37.495
|
30.415
|
-
|
-
|
Bedrijfswaarde
1 |
51.733
|
41.723
|
37.820
|
40.560
|
43.384
|
33.795
|
30.764
|
27.056
|
K/w-verhouding
|
9,44
x
|
9,87
x
|
23,1
x
|
13,3
x
|
32,5
x
|
15,9
x
|
13,8
x
|
11,4
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
3,72
x
|
2,8
x
|
3,21
x
|
3,92
x
|
3,81
x
|
3,19
x
|
3,19
x
|
3,08
x
|
Bedrijfswaarde/omzet
|
3,6
x
|
3,1
x
|
3,44
x
|
3,99
x
|
4,41
x
|
3,55
x
|
3,23
x
|
2,74
x
|
Bedrijfswaarde/EBITDA
|
6,41
x
|
5,56
x
|
9,13
x
|
11,2
x
|
14,3
x
|
10
x
|
8,42
x
|
6,58
x
|
Bedrijfswaarde/FCF
|
7,88
x
|
11
x
|
11,2
x
|
35,5
x
|
34,2
x
|
14,7
x
|
11,1
x
|
9,18
x
|
FCF Yield
|
12,7%
|
9,12%
|
8,94%
|
2,82%
|
2,93%
|
6,81%
|
9,02%
|
10,9%
|
Price to Book
|
3,87
x
|
3,7
x
|
3,26
x
|
3,02
x
|
2,53
x
|
1,77
x
|
1,56
x
|
1,37
x
|
Aantal aandelen (in duizenden)
|
180.442
|
153.882
|
146.893
|
144.001
|
144.898
|
145.597
|
-
|
-
|
Referentieprijs
2 |
296,7
|
244,9
|
239,9
|
276,9
|
258,8
|
208,9
|
208,9
|
208,9
|
Datum van publicatie
|
30/01/20
|
3/02/21
|
3/02/22
|
15/02/23
|
13/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
14.378
|
13.445
|
10.982
|
10.173
|
9.836
|
9.524
|
9.538
|
9.859
|
EBITDA
1 |
8.070
|
7.504
|
4.144
|
3.618
|
3.040
|
3.371
|
3.653
|
4.112
|
Bedrijfsresultaat (EBIT)
1 |
7.390
|
6.837
|
3.656
|
3.099
|
2.545
|
2.858
|
3.074
|
3.332
|
Operationele Marge
|
51,4%
|
50,85%
|
33,3%
|
30,47%
|
25,87%
|
30,01%
|
32,23%
|
33,8%
|
Resultaat voor belastingen (EBT)
1 |
7.126
|
5.048
|
1.745
|
3.592
|
1.297
|
2.266
|
2.786
|
3.423
|
Nettowinst (verlies)
1 |
5.888
|
4.001
|
1.556
|
3.047
|
1.161
|
1.894
|
2.217
|
2.653
|
Nettomarge
|
40,96%
|
29,76%
|
14,17%
|
29,95%
|
11,8%
|
19,89%
|
23,24%
|
26,91%
|
WPA
2 |
31,42
|
24,80
|
10,40
|
20,87
|
7,970
|
13,13
|
15,14
|
18,39
|
Free Cash Flow
1 |
6.564
|
3.805
|
3.382
|
1.144
|
1.270
|
2.300
|
2.776
|
2.949
|
FCF-marge
|
45,65%
|
28,3%
|
30,8%
|
11,25%
|
12,91%
|
24,15%
|
29,1%
|
29,91%
|
Kasstroomconversie (ebitda)
|
81,34%
|
50,71%
|
81,61%
|
31,62%
|
41,79%
|
68,24%
|
76%
|
71,71%
|
Kasstroomconversie (nettowinst)
|
111,47%
|
95,11%
|
217,34%
|
37,55%
|
109,4%
|
121,44%
|
125,2%
|
111,13%
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
30/01/20
|
3/02/21
|
3/02/22
|
15/02/23
|
13/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Omzet
1 |
2.734
|
2.532
|
2.589
|
2.508
|
2.544
|
2.463
|
2.456
|
2.530
|
2.386
|
2.290
|
2.378
|
2.404
|
2.448
|
2.365
|
2.413
|
EBITDA
1 |
780,7
|
844,1
|
1.112
|
991
|
792,7
|
674,7
|
797,7
|
853,1
|
697,5
|
795,5
|
956,5
|
981,6
|
1.024
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
646
|
708,6
|
976,7
|
870
|
672,9
|
467,5
|
674,2
|
728,1
|
557,4
|
648
|
709,6
|
731,9
|
726,5
|
718,1
|
751,9
|
Operationele Marge
|
23,63%
|
27,99%
|
37,72%
|
34,68%
|
26,45%
|
18,98%
|
27,45%
|
28,78%
|
23,36%
|
28,29%
|
29,84%
|
30,44%
|
29,68%
|
30,37%
|
31,15%
|
Resultaat voor belastingen (EBT)
1 |
405
|
347,4
|
1.270
|
1.371
|
603,8
|
438,3
|
708,1
|
-141,2
|
291,6
|
464,8
|
627,3
|
545
|
549,5
|
512,5
|
526,5
|
Nettowinst (verlies)
1 |
368,2
|
303,8
|
1.058
|
1.135
|
550,4
|
387,9
|
591,6
|
-68,1
|
249,7
|
393,4
|
524,2
|
480,2
|
488,6
|
458
|
488,3
|
Nettomarge
|
13,47%
|
12%
|
40,86%
|
45,23%
|
21,64%
|
15,75%
|
24,09%
|
-2,69%
|
10,47%
|
17,18%
|
22,04%
|
19,97%
|
19,96%
|
19,37%
|
20,23%
|
WPA
2 |
2,500
|
2,060
|
7,240
|
7,840
|
3,790
|
2,670
|
4,070
|
-0,4700
|
1,710
|
2,700
|
3,587
|
3,176
|
3,351
|
3,290
|
3,405
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
3/02/22
|
3/05/22
|
20/07/22
|
25/10/22
|
15/02/23
|
25/04/23
|
25/07/23
|
8/11/23
|
13/02/24
|
24/04/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
4.044
|
2.578
|
683
|
5.888
|
3.380
|
349
|
-
|
Nettokaspositie
1 |
1.810
|
-
|
-
|
-
|
-
|
-
|
-
|
3.359
|
Hefboom (schuld/ebitda)
|
-
|
0,5389
x
|
0,6221
x
|
0,1888
x
|
1,937
x
|
1,003
x
|
0,0954
x
|
-
|
Free Cash Flow
1 |
6.564
|
3.805
|
3.382
|
1.144
|
1.270
|
2.300
|
2.776
|
2.949
|
ROE (netto-inkomsten/eigen vermogen)
|
47,7%
|
45,2%
|
26,6%
|
21,2%
|
15,2%
|
14,1%
|
14,5%
|
14,2%
|
ROA (netto-inkomsten/totale activa)
|
24%
|
15,4%
|
11,9%
|
12,6%
|
4,52%
|
7,56%
|
7,57%
|
7,86%
|
Totale activa
1 |
24.583
|
25.927
|
13.124
|
24.216
|
25.699
|
25.041
|
29.272
|
33.763
|
Nettoactief per aandeel
2 |
76,60
|
66,20
|
73,50
|
91,70
|
102,0
|
118,0
|
134,0
|
153,0
|
Cashflow per aandeel
2 |
38,00
|
26,20
|
24,30
|
9,480
|
10,60
|
15,50
|
20,50
|
26,90
|
Capex
1 |
515
|
425
|
258
|
240
|
277
|
298
|
289
|
289
|
Capex/omzet
|
3,58%
|
3,16%
|
2,35%
|
2,36%
|
2,82%
|
3,13%
|
3,03%
|
2,93%
|
Datum van publicatie
|
30/01/20
|
3/02/21
|
3/02/22
|
15/02/23
|
13/02/24
|
-
|
-
|
-
|
Laatste slotkoers
208,9
USD Gemiddelde koersdoel
285,9
USD Spread / Gemiddelde doel +36,84% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -19,27% | 30,42 mld. | | -4,66% | 86,13 mld. | | +1,32% | 39,82 mld. | | +57,86% | 25,23 mld. | | -17,69% | 11,6 mld. | | -43,00% | 11,51 mld. | | -9,14% | 11,95 mld. | | +5,24% | 8,71 mld. | | -8,42% | 8,12 mld. | | +2,29% | 7,72 mld. |
Biofarmaceutica
|